The Neo-PLANET phase II trial of neoadjuvant camrelizumab plus concurrent chemoradiotherapy in locally advanced adenocarcinoma of stomach or gastroesophageal junction
Zhaoqing Tang(Sun Yat-sen University), Yihong Sun(Fudan University)
Cited by 82
Related Papers
High expression of CD39 in gastric cancer reduces patient outcome following radical resection
|Oncology Letters|2016|57